Memphis Pharmaceuticals (MPCI.CA) - Board of Directors' Decisions
Company Name : Memphis Pharmaceuticals
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
The Board of Directors' decision held on 24/10/2020 concerning the unaudited financial results for the period ended 30/09/2020.
News Attachment I (205 KB)
News Attachment II (279 KB)
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
The Board of Directors' decision held on 24/10/2020 concerning the unaudited financial results for the period ended 30/09/2020.
News Attachment I (205 KB)
News Attachment II (279 KB)
Comments